Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-10

FDA Approved: VOGELXO — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Vogelxo (testosterone) by Upsher-Smith Laboratories, LLC, approving changes to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOGELXO (TESTOSTERONE)

Snippet

SUPPL AP for VOGELXO (TESTOSTERONE)